Delivery Order SPE2DB20D3101-SPE2DB24FQVD9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,582.63, is a Firm Fixed Price Delivery Order for 4567854243 ! DEPAKOTE DR 125 MG SPRINKLE CP 100S. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.48 delivery order contract is for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a firm fixed price pricing type and a completion date of June 29, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $1,067.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. for the delivery of 4,565,232 units of Depakote DR 125 mg Sprinkle capsules. The contract has a completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, with a ceiling value of $1,824.98 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,367.22 firm fixed-price delivery order is for the supply of 4565941126 - DEPAKOTE DR 125 MG SPRINKLE CP 100S, a pharmaceutical product. The contract has a completion date of September 26, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,548,337 units of the medication Depakote DR 125 mg sprinkle capsules, with an ultimate completion date of June 16, 2025 and a ceiling value of $2,055.23. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,246.32, was awarded by the Defense Logistics Agency (DLA) to provide a range of pharmaceutical products and medical supplies, including medications across therapeutic areas such as diabetes, neurology, pain management, and more. The contract has an ultimate completion date of July 11, 2025 and is a firm fixed-price...
- The Defense Logistics Agency (DLA) awarded a firm fixed price Delivery Order contract worth $1,182.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the supply of pharmaceutical products, including a 0.25% 10ML medication, to support military treatment programs and facilities. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA,...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a Firm Fixed Price Delivery Order contract valued at $1,598.40 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract, which has a completion date of June 27, 2024, is for the provision of pharmaceutical products and medical supplies to the DLA. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQVD9Delivery Order
This federal contract award is for the delivery of 4562896074 - DEPAKOTE DR 125 MG SPRINKLE CP 100S to the Defense Logistics Agency (DLA). The contract, valued at $1,434.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a firm fixed price and an ultimate completion date of November 27, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/24/23 |